background
chemokin
play
import
role
inflamm
antivir
action
examin
whether
polymorph
rant
mig
affect
suscept
outcom
sever
acut
respiratori
syndrom
sar
test
polymorph
rant
mig
associ
sar
hong
kong
chines
sar
patient
control
tri
confirm
result
beij
chines
sar
patient
control
result
rant
g
allel
associ
sar
suscept
hong
kong
chines
p
individu
rant
cg
gg
genotyp
increas
risk
develop
sar
respect
p
g
allel
confer
risk
death
genedosag
depend
manner
p
cg
gg
individu
ci
ci
increas
risk
replic
rant
data
beij
chines
g
allel
associ
suscept
sar
howev
cg
gg
associ
admiss
intens
care
unit
death
due
sar
p
sever
acut
respiratori
syndrom
sar
infecti
diseas
caus
sar
coronaviru
case
death
report
pathogenesi
sar
complex
host
genet
background
one
factor
determin
suscept
outcom
demonstr
genet
haplotyp
associ
low
serum
mannosebind
lectin
mbl
associ
sar
find
confirm
anoth
independ
studi
furthermor
show
interferon
gamma
gene
polymorph
associ
sar
suscept
gene
liverlymph
nodespecif
nonintegrin
lsign
encod
synthetas
gene
myxoviru
resist
mxa
also
identifi
chemokin
play
import
role
cell
traffick
immun
respons
acut
respiratori
virus
commonli
induc
inflammatori
chemokin
local
tissu
case
sar
previou
studi
confirm
sar
coronaviru
induc
upregul
number
inflammatoemokin
ie
regul
upon
activ
normal
cellexpress
secret
rant
interferongamma
induc
protein
monocyt
chemoattract
upregul
chemokin
recruit
inflammatori
cell
leukocyt
tissu
therefor
hypothes
polymorph
inflammatori
chemokin
gene
might
associ
sar
studi
investig
singl
nucleotid
polymorph
snp
inflammatori
chemokin
gene
ie
rant
monokin
induc
gamma
interferon
gene
mig
two
chines
cohort
hong
kong
beij
found
rant
g
allel
associ
diseas
suscept
sever
sar
studi
includ
hong
kong
chines
patient
sar
mean
sd
age
year
male
femal
tabl
least
patient
document
sarscov
antibodi
seroconvers
andor
detect
sarscov
rna
respiratori
secret
rtpcr
describ
previous
studi
approv
studi
grant
clinic
research
ethic
committe
institut
review
board
univers
hong
konghospit
author
hong
kong
west
cluster
patient
divid
two
group
death
group
surviv
group
death
group
consist
patient
die
sar
mean
sd
age
year
male
femal
surviv
group
consist
patient
mean
sd
age
year
male
femal
popul
hong
kong
chines
compris
healthi
red
cross
blood
donor
serv
control
subject
mean
sd
age
year
male
femal
tabl
three
hundr
fifti
six
beij
chines
patient
sar
recruit
describ
previous
mean
sd
age
male
femal
tabl
among
patient
classifi
sever
group
identifi
admiss
intens
care
unit
death
sar
mean
sd
age
male
femal
remain
patient
classifi
mild
group
mean
sd
age
male
femal
total
ethnic
match
healthi
individu
mean
age
sd
male
femal
serv
control
tabl
rant
genotyp
polymeras
chain
reactionrestrict
fragment
length
polymorph
pcrrflp
describ
previous
rant
rant
mig
genotyp
massarray
system
sequenom
san
diego
ca
brief
sampl
amplifi
reaction
mixtur
contain
ng
genom
dna
pmol
specif
forward
revers
primer
dntp
mm
mgcl
unit
hotstartaq
polymeras
qiagen
valencia
ca
pcr
condit
includ
initi
hotstart
min
cycl
amplif
sec
sec
min
final
extens
min
pcr
product
treat
alkalin
phosphatas
dephosphoryl
residu
amplif
nucleotid
mixtur
hme
buffer
shrimp
alkalin
phosphatas
sequenom
ddh
ad
pcr
product
reaction
solut
incub
min
follow
min
inactiv
enzym
massextend
reaction
determin
genotyp
perform
four
group
differ
termin
accord
design
rational
ddacg
ddact
ddagt
ddcgt
respect
reaction
volum
includ
unit
thermosequenas
sequenom
respect
termin
mix
pmol
assay
specif
extens
primer
tabl
assay
run
thermal
cycl
condit
initi
denatur
min
follow
cycl
extens
sec
sec
sec
product
massextend
reaction
desalt
transfer
onto
spectrochip
nanolit
dispens
accord
manufactur
instruct
sequenom
genotyp
determin
perform
malditof
mass
spectromet
sequenom
mass
spectrometr
data
automat
import
spectrotyp
sequenom
databas
data
analysi
includ
nois
normal
peak
area
analysi
expect
molecular
weight
relev
peak
calcul
massarray
assaydesign
softwar
sequenom
analysi
identifi
mass
spectrum
everi
plate
assay
one
well
blank
control
five
well
duplic
check
five
sampl
intern
qualiti
control
twostep
analysi
use
determin
associ
polymorph
sar
genotyp
frequenc
allel
frequenc
gene
compar
sar
patient
control
chisquar
test
chisquar
test
respect
logist
regress
use
calcul
odd
ratio
confid
interv
correspond
pvalu
differ
genotyp
frequenc
among
sar
patient
control
adjust
age
sex
signific
singl
nucleotid
polymorph
snp
associ
outcom
sar
infect
death
vs
surviv
test
compar
genotyp
frequenc
allel
frequenc
gene
death
group
surviv
group
sar
patient
chisquar
test
chisquar
test
respect
genotyp
frequenc
snp
test
hardyweinberg
equilibrium
hwe
separ
sar
patient
control
chisquar
test
signific
pvalu
multipl
test
adjust
bonferroni
correct
statist
analysi
perform
sa
version
sasgenet
sa
institut
inc
nc
usa
rant
rant
rant
mig
genotyp
sar
patient
control
hong
kong
genotyp
allel
frequenc
shown
tabl
respect
rant
cg
gg
genotyp
significantli
associ
sar
suscept
ci
ci
respect
p
tabl
rant
g
allel
also
significantli
increas
patient
p
ci
tabl
correct
bonferroni
method
signific
p
valu
less
associ
rant
sar
suscept
remain
signific
compar
genotyp
allel
frequenc
rant
death
group
surviv
group
sar
patient
rant
g
allel
associ
death
sar
genedosag
depend
manner
p
cg
gg
individu
ci
ci
increas
risk
death
sar
respect
tabl
confirm
associ
rant
sar
studi
three
rant
snp
beij
chines
cohort
three
hundr
fifti
six
sar
patient
healthi
control
genotyp
genotyp
allel
frequenc
shown
tabl
genotyp
distribut
two
group
hwe
signific
differ
observ
frequenc
snp
patient
control
next
investig
associ
rant
sar
sever
twenti
patient
classifi
sever
group
defin
admiss
intens
care
unit
death
due
sar
genotyp
allel
frequenc
snp
sever
mild
patient
shown
tabl
genotyp
distribut
among
two
group
significantli
differ
p
frequenc
cg
gg
genotyp
overrepres
sever
group
cg
ci
gg
ci
frequenc
g
allel
also
significantli
increas
sever
group
ci
p
describ
hong
kong
chines
rant
gg
genotyp
ci
ci
increas
risk
develop
sar
respect
p
tabl
g
allel
also
increas
risk
death
hong
kong
chines
patient
sar
genedosag
depend
tabl
importantli
confirm
associ
rant
cg
sever
sar
studi
beij
chines
cohort
found
beij
chines
patient
cg
ci
gg
ci
genotyp
sever
defin
admiss
intens
care
unit
death
due
sar
investig
associ
rant
sar
also
perform
haplotyp
analysi
use
studi
snp
rant
ie
g
construct
haplotyp
howev
major
effect
haplotyp
due
snp
rant
data
shown
rant
respons
recruit
eosinophil
lymphocyt
monocyt
basophil
site
inflamm
involv
mani
viral
infect
found
g
allel
rant
associ
suscept
death
sar
inde
rant
locat
bind
site
confirm
gelmobl
shift
assay
mean
snp
may
involv
regul
rant
express
vitro
studi
show
rant
g
allel
enhanc
bind
lead
elev
promot
activ
increas
rant
express
cell
cell
monocyt
macrophag
therefor
togeth
observ
g
allel
associ
sar
conclud
ns
signific
pvalu
ci
calcul
use
logist
regress
model
adjust
sex
age
correct
bonferroni
method
signific
p
valu
less
studi
show
rant
g
allel
risk
factor
associ
sever
clinic
outcom
hong
kong
beij
chines
sar
patient
note
mani
cytokineschemokin
releas
activ
immun
cell
take
part
process
antivir
immun
respons
also
involv
cell
damag
organ
dysfunct
apart
chemokin
receptor
signal
pathway
rant
could
activ
cell
herbimycin
asensit
protein
tyrosin
kinas
ptk
mediat
pathway
high
concentr
trigger
releas
inflammatori
cytokin
chemokin
recent
demonstr
sar
coronaviru
induc
high
level
express
chemokin
human
dendrit
cell
high
level
rant
may
intensifi
lung
inflamm
lead
lymphopenia
increas
chanc
secondari
infect
henc
death
rate
among
sar
patient
therefor
specul
g
allel
associ
higher
level
rant
may
enhanc
inflamm
lead
sever
clinic
outcom
sar
ns
signific
pvalu
ci
calcul
use
logist
regress
model
adjust
sex
age
inde
rant
g
allel
show
strong
associ
death
hong
kong
chines
patient
sar
tabl
observ
confirm
beij
chines
rant
g
allel
associ
admiss
intens
care
unit
death
due
sar
tabl
case
sar
suscept
rant
g
allel
associ
hong
kong
chines
patient
beij
chines
patient
suggest
chines
southern
northern
china
may
genet
distinct
account
differ
observ
regard
sar
suscept
demonstr
rant
g
allel
correl
high
rant
product
associ
sar
suscept
hong
kong
chines
also
associ
advers
outcom
sar
hong
kong
beij
chines
suggest
high
rant
level
may
play
role
pathogenesi
sar
